Citations (49)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Shilong Song, Xiaoxiao Jin, Lei Zhang, Chen Zhao, Yan Ding, Qianqian Ang, Odontuya Khaidav & Chuanlai Shen. (2019) PEGylated and CD47-conjugated nanoellipsoidal artificial antigen-presenting cells minimize phagocytosis and augment anti-tumor T-cell responses. International Journal of Nanomedicine 14, pages 2465-2483.
Read now
Read now
Duy Hieu Truong, Thi Thu Phuong Tran, Hanh Thuy Nguyen, Cao Dai Phung, Tung Thanh Pham, Chul Soon Yong, Jong Oh Kim & Tuan Hiep Tran. (2019) Modulating T-cell-based cancer immunotherapy via particulate systems. Journal of Drug Targeting 27:2, pages 145-163.
Read now
Read now
Jacques Thibodeau, Marie-Claude Bourgeois-Daigneault & Réjean Lapointe. (2012) Targeting the MHC Class II antigen presentation pathway in cancer immunotherapy. OncoImmunology 1:6, pages 908-916.
Read now
Read now
Articles from other publishers (46)
Yuchen Hou & Bebhinn Treanor. (2023) DNA origami: Interrogating the nano-landscape of immune receptor activation. Biophysical Journal.
Crossref
Crossref
Daniela Mateus, Ana I. Sebastião, Manuela F. Frasco, Mylène A. Carrascal, Amílcar Falcão, Célia M. Gomes, Bruno Neves, Maria G. F. Sales & Maria T. Cruz. (2023) Artificial Dendritic Cells: A New Era of Promising Antitumor Immunotherapy. Small.
Crossref
Crossref
Faris Alrumaihi. (2022) The Multi-Functional Roles of CCR7 in Human Immunology and as a Promising Therapeutic Target for Cancer Therapeutics. Frontiers in Molecular Biosciences 9.
Crossref
Crossref
Shaobo Ruan, Yuanyu Huang, Mei He & Huile Gao. (2022) Advanced Biomaterials for Cell‐Specific Modulation and Restore of Cancer Immunotherapy. Advanced Science 9:16, pages 2200027.
Crossref
Crossref
Thai Minh Duy Le, A-Rum Yoon, Thavasyappan Thambi & Chae-Ok Yun. (2022) Polymeric Systems for Cancer Immunotherapy: A Review. Frontiers in Immunology 13.
Crossref
Crossref
Elana Ben-Akiva, Johan Karlsson, Stephany Y. Tzeng, Hongzhe Yu & Jordan J. Green. 2022. Systemic Drug Delivery Strategies. Systemic Drug Delivery Strategies
31
62
.
Jun‐Long Liang, Guo‐Feng Luo, Wei‐Hai Chen & Xian‐Zheng Zhang. (2021) Recent Advances in Engineered Materials for Immunotherapy‐Involved Combination Cancer Therapy. Advanced Materials 33:31, pages 2007630.
Crossref
Crossref
Jung‐Chen Lin, Chung‐Yao Hsu, Jui‐Yi Chen, Zih‐Syun Fang, Hui‐Wen Chen, Bing‐Yu Yao, Gwo Harn M. Shiau, Jeng‐Shiang Tsai, Ming Gu, Meiying Jung, Tong‐Young Lee & Che‐Ming J. Hu. (2021) Facile Transformation of Murine and Human Primary Dendritic Cells into Robust and Modular Artificial Antigen‐Presenting Systems by Intracellular Hydrogelation. Advanced Materials 33:30, pages 2101190.
Crossref
Crossref
Chunxiong Zheng, Jiabin Zhang, Hon Fai Chan, Hanze Hu, Shixian Lv, Ning Na, Yu Tao & Mingqiang Li. (2021) Engineering Nano‐Therapeutics to Boost Adoptive Cell Therapy for Cancer Treatment. Small Methods 5:5, pages 2001191.
Crossref
Crossref
Robby Divine, Ha V. Dang, George Ueda, Jorge A. Fallas, Ivan Vulovic, William Sheffler, Shally Saini, Yan Ting ZhaoInfencia Xavier Raj, Peter A. Morawski, Madeleine F. Jennewein, Leah J. Homad, Yu-Hsin Wan, Marti R. TooleyFranziska SeegerAli EtemadiMitchell L. Fahning, James Lazarovits, Alex Roederer, Alexandra C. Walls, Lance Stewart, Mohammadali Mazloomi, Neil P. King, Daniel J. Campbell, Andrew T. McGuire, Leonidas Stamatatos, Hannele Ruohola-Baker, Julie Mathieu, David Veesler & David Baker. (2021) Designed proteins assemble antibodies into modular nanocages. Science 372:6537.
Crossref
Crossref
Xinyue Wang, Fanyan Meng, Ying‐Tzu Yen, Rutian Li & Baorui Liu. (2020) Nanotechnology‐Based CAR‐T Strategies for Improving Efficacy and Safety of Tumor Immunotherapy. Advanced Functional Materials 31:1, pages 2004713.
Crossref
Crossref
C. Wyatt ShieldsIVIV, Lily Li‐Wen Wang, Michael A. Evans & Samir Mitragotri. (2019) Materials for Immunotherapy. Advanced Materials 32:13, pages 1901633.
Crossref
Crossref
Weijing Yang, Zijian Zhou, Joseph Lau, Shuo Hu & Xiaoyuan Chen. (2019) Functional T cell activation by smart nanosystems for effective cancer immunotherapy. Nano Today 27, pages 28-47.
Crossref
Crossref
Enping Hong & Marina A. Dobrovolskaia. (2019) Addressing barriers to effective cancer immunotherapy with nanotechnology: achievements, challenges, and roadmap to the next generation of nanoimmunotherapeutics. Advanced Drug Delivery Reviews 141, pages 3-22.
Crossref
Crossref
Kelly R. Rhodes & Jordan J. Green. (2018) Nanoscale artificial antigen presenting cells for cancer immunotherapy. Molecular Immunology 98, pages 13-18.
Crossref
Crossref
. 2017. Nanomedicine in Cancer. Nanomedicine in Cancer
235
264
.
Elana Ben-Akiva, Randall A. Meyer, David R. Wilson & Jordan J. Green. (2017) Surface engineering for lymphocyte programming. Advanced Drug Delivery Reviews 114, pages 102-115.
Crossref
Crossref
Alyssa L. Siefert, Tarek M. Fahmy & Dongin Kim. 2017. Cancer Nanotechnology. Cancer Nanotechnology
343
353
.
Anke Redeker & Ramon Arens. (2016) Improving Adoptive T Cell Therapy: The Particular Role of T Cell Costimulation, Cytokines, and Post-Transfer Vaccination. Frontiers in Immunology 7.
Crossref
Crossref
Ilona Dudek, Marta Skoda, Anna Jarosz & Dariusz Szukiewicz. (2015) The Molecular Influence of Graphene and Graphene Oxide on the Immune System Under In Vitro and In Vivo Conditions. Archivum Immunologiae et Therapiae Experimentalis 64:3, pages 195-215.
Crossref
Crossref
Enping Hong, Ilana M. Usiskin, Cristina Bergamaschi, Douglas J. Hanlon, Richard L. Edelson, Sune Justesen, George N. Pavlakis, Richard A. Flavell & Tarek M. Fahmy. (2016) Configuration-dependent Presentation of Multivalent IL-15:IL-15Rα Enhances the Antigen-specific T Cell Response and Anti-tumor Immunity. Journal of Biological Chemistry 291:17, pages 8931-8950.
Crossref
Crossref
Ilia Platzman, Gerri Kannenberg, Jan-Willi Janiesch, Jovana Mati?Joachim P. Spatz. 2015. Soft Matter Nanotechnology. Soft Matter Nanotechnology
187
216
.
Michael Labowsky, Justin Lowenthal & Tarek M Fahmy. (2015) An in silico analysis of nanoparticle/cell diffusive transfer: Application to nano-artificial antigen-presenting cell:T-cell interaction. Nanomedicine: Nanotechnology, Biology and Medicine 11:4, pages 1019-1028.
Crossref
Crossref
Minami Iwabuchi, Miwako Narita, Takayoshi Uchiyama, Shunpei Iwaya, Eri Oiwa, Yoshinori Nishizawa, Shigeo Hashimoto, Aude Bonehill, Noriyuki Kasahara, Jun Takizawa & Masuhiro Takahashi. (2015) Enhancement of the antigen‑specific cytotoxic T�lymphocyte‑inducing ability in the PMDC11 leukemic plasmacytoid dendritic cell line via lentiviral vector‑mediated transduction of the caTLR4 gene. Molecular Medicine Reports.
Crossref
Crossref
Nicasio Mancini, Lara Marrone, Nicola Clementi, Giuseppe A Sautto, Massimo Clementi & Roberto Burioni. (2015) Adoptive T-cell therapy in the treatment of viral and opportunistic fungal infections. Future Microbiology 10:4, pages 665-682.
Crossref
Crossref
Karlo Perica, Alyssa K. Kosmides & Jonathan P. Schneck. (2015) Linking form to function: Biophysical aspects of artificial antigen presenting cell design. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1853:4, pages 781-790.
Crossref
Crossref
Randall A. Meyer & Jordan J. Green. 2015. Biomaterials in Regenerative Medicine and the Immune System. Biomaterials in Regenerative Medicine and the Immune System
257
277
.
Loek J. Eggermont, Leonie E. Paulis, Jurjen Tel & Carl G. Figdor. (2014) Towards efficient cancer immunotherapy: advances in developing artificial antigen-presenting cells. Trends in Biotechnology 32:9, pages 456-465.
Crossref
Crossref
Tarek R. Fadel, Fiona A. Sharp, Nalini Vudattu, Ragy Ragheb, Justin Garyu, Dongin Kim, Enping Hong, Nan Li, Gary L. Haller, Lisa D. Pfefferle, Sune Justesen, Kevan C. Herold & Tarek M. Fahmy. (2014) A carbon nanotube–polymer composite for T-cell therapy. Nature Nanotechnology 9:8, pages 639-647.
Crossref
Crossref
Tarek R. Fadel & Tarek M. Fahmy. (2014) Immunotherapy applications of carbon nanotubes: from design to safe applications. Trends in Biotechnology 32:4, pages 198-209.
Crossref
Crossref
Karlo Perica, Ang Tu, Anne Richter, Joan Glick Bieler, Michael Edidin & Jonathan P. Schneck. (2014) Magnetic Field-Induced T Cell Receptor Clustering by Nanoparticles Enhances T Cell Activation and Stimulates Antitumor Activity. ACS Nano 8:3, pages 2252-2260.
Crossref
Crossref
Piotr Grodzinski & Dorothy Farrell. (2014) Future Opportunities in Cancer Nanotechnology—NCI Strategic Workshop Report. Cancer Research 74:5, pages 1307-1310.
Crossref
Crossref
Joep van der Weijden, Leonie E. Paulis, Martijn Verdoes, Jan C. M. van Hest & Carl G. Figdor. (2014) The right touch: design of artificial antigen-presenting cells to stimulate the immune system. Chemical Science 5:9, pages 3355.
Crossref
Crossref
Karlo Perica, Andrés De León Medero, Malarvizhi Durai, Yen Ling Chiu, Joan Glick Bieler, Leah Sibener, Michaela Niemöller, Mario Assenmacher, Anne Richter, Michael Edidin, Mathias Oelke & Jonathan Schneck. (2014) Nanoscale artificial antigen presenting cells for T cell immunotherapy. Nanomedicine: Nanotechnology, Biology and Medicine 10:1, pages 119-129.
Crossref
Crossref
Joel C. Sunshine, Karlo Perica, Jonathan P. Schneck & Jordan J. Green. (2014) Particle shape dependence of CD8+ T cell activation by artificial antigen presenting cells. Biomaterials 35:1, pages 269-277.
Crossref
Crossref
Jovana Matic, Janosch Deeg, Alexander Scheffold, Itamar Goldstein & Joachim P. Spatz. (2013) Fine Tuning and Efficient T Cell Activation with Stimulatory aCD3 Nanoarrays. Nano Letters 13:11, pages 5090-5097.
Crossref
Crossref
Ilia Platzman, Jan-Willi Janiesch, Jovana Mati?Joachim P. Spatz. (2013) Artificial Antigen-Presenting Interfaces in the Service of Immunology. Israel Journal of Chemistry, pages n/a-n/a.
Crossref
Crossref
Babak Kateb & John HeissJoel Sunshine, Zachary Guss, Jay Pillai & Michael Lim. 2013. The Textbook of Nanoneuroscience and Nanoneurosurgery. The Textbook of Nanoneuroscience and Nanoneurosurgery
395
402
.
M. Labowsky & T.M. Fahmy. (2013) Effect of cell surface deformation on synaptic factor accumulation during the early stages of T cell activation. Chemical Engineering Science 90, pages 275-283.
Crossref
Crossref
Chuanlai Shen, Kai Cheng, Shenwei Miao, Wei Wang, Yong He, Fanyan Meng & Jianqiong Zhang. (2013) Latex bead-based artificial antigen-presenting cells induce tumor-specific CTL responses in the native T-cell repertoires and inhibit tumor growth. Immunology Letters 150:1-2, pages 1-11.
Crossref
Crossref
Matthew F. Mescher & Julie M. Curtsinger. 2012. Vaccinology. Vaccinology
286
299
.
Stephen C. Balmert & Steven R. Little. (2012) Biomimetic Delivery with Micro- and Nanoparticles. Advanced Materials 24:28, pages 3757-3778.
Crossref
Crossref
Erin R. Steenblock, Tarek Fadel, Michael Labowsky, Jordan S. Pober & Tarek M. Fahmy. (2011) An Artificial Antigen-presenting Cell with Paracrine Delivery of IL-2 Impacts the Magnitude and Direction of the T Cell Response. Journal of Biological Chemistry 286:40, pages 34883-34892.
Crossref
Crossref
Akie Yamahira, Miwako Narita, Takeshi Nakamura, Norihiro Watanabe, Masami Kaji, Tomoyo Taniguchi, Shigeo Hashimoto, Tatsuo Furukawa, Ken Toba, Yoshifusa Aizawa, Kiyotaka Kuzushima & Masuhiro Takahashi. (2011) Generation of antigen-specific cytotoxic T lymphocytes using a leukemic plasmacytoid dendritic cell line as antigen presenting cells. Leukemia Research 35:6, pages 793-799.
Crossref
Crossref
Jacques Thibodeau, Marie-Claude Bourgeois-Daigneault & Réjean Lapointe. 2011. Experimental and Applied Immunotherapy. Experimental and Applied Immunotherapy
173
194
.
Cameron J. Turtle & Stanley R. Riddell. (2010) Artificial Antigen-Presenting Cells for Use in Adoptive Immunotherapy. The Cancer Journal 16:4, pages 374-381.
Crossref
Crossref